Basel Medical (BMGL) Short term Debt (2024 - 2025)
Basel Medical (BMGL) has disclosed Short term Debt for 2 consecutive years, with $1.6 million as the latest value for Q2 2025.
- Quarterly Short term Debt rose 68.12% to $1.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jun 2025, up 68.12% year-over-year, with the annual reading at $1.6 million for FY2025, 68.12% up from the prior year.
- Short term Debt hit $1.6 million in Q2 2025 for Basel Medical, up from $969283.9 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.6 million in Q2 2025 to a low of $969283.9 in Q2 2024.